Can Amyloidosis Affect the Skin?
Yes, amyloidosis can definitely affect the skin, particularly in AL (light chain) amyloidosis where skin involvement occurs as an important extracardiac manifestation that can provide diagnostic clues.
Skin Manifestations by Amyloidosis Type
AL (Light Chain) Amyloidosis - Most Common Skin Involvement
Skin is a recognized organ of involvement in systemic AL amyloidosis 1. The most characteristic and clinically important cutaneous manifestations include:
- Periorbital ecchymoses ("raccoon eyes") - This is a classic atypical manifestation that should prompt immediate evaluation for AL amyloidosis 2
- Purpura, petechiae, and ecchymoses - Result from amyloid infiltration of blood vessel walls, representing the most common skin lesions 3
- Waxy papules and plaques - Can appear flesh-colored or brown, with smooth or warty surfaces 4
- Macroglossia - While technically mucosal, this is another atypical manifestation highly suggestive of AL amyloidosis 2
The skin involvement in AL amyloidosis has significant diagnostic and prognostic implications. Mucocutaneous manifestations occur in approximately 35% of systemic amyloidosis cases, with AL type showing significantly higher rates (50%) compared to other types (20%) 5.
Other Amyloidosis Types
- Hereditary (TTR) amyloidosis: Variable skin involvement 1
- Senile (wild-type TTR) amyloidosis: Diffuse organ involvement possible 1
- AA (Reactive) amyloidosis: Rarely affects the heart or skin 1
Clinical Significance for Diagnosis
The presence of skin manifestations should trigger immediate workup for systemic amyloidosis, especially when combined with other features. The 2023 ACC Expert Consensus specifically identifies periorbital ecchymoses as an atypical manifestation warranting evaluation for AL amyloidosis 2.
Key Diagnostic Approach When Skin Involvement is Present:
Skin biopsy is a valuable diagnostic tool - Fine-needle aspiration or biopsy of affected skin can demonstrate amyloid deposits with Congo red staining showing apple-green birefringence 1
Surrogate site for diagnosis - Skin can serve as an accessible biopsy site when systemic amyloidosis is suspected, though abdominal fat pad aspiration has higher sensitivity (84% for AL-CM) 2
Mass spectrometry typing is essential - Once amyloid is detected, LC-MS/MS should be performed to identify the precursor protein type, as this determines treatment strategy 2
Common Pitfalls to Avoid
- Don't dismiss purpura or periorbital ecchymoses as simple bruising - These can be the first clue to underlying AL amyloidosis, particularly when occurring without significant trauma
- Don't assume all skin involvement is the same - The pattern and distribution differ significantly between AL (50% involvement) and other types (20% involvement) 5
- Don't forget that skin manifestations often appear with multi-organ involvement - Over 69% of patients have more than one organ involved at diagnosis 6, so evaluate for cardiac, renal, and neurologic involvement
Primary Localized Cutaneous Amyloidosis (PLCA)
It's important to distinguish systemic amyloidosis with skin involvement from primary localized cutaneous amyloidosis (PLCA), which is a separate entity where amyloid deposits are confined to the skin without systemic involvement 7, 8. PLCA includes lichen amyloidosis, macular amyloidosis, and nodular amyloidosis, and does not carry the same mortality risk as systemic disease.